Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) Return on Equity (2017 - 2025)

ENDRA Life Sciences has reported Return on Equity over the past 5 years, most recently at 0.01% for Q4 2021.

  • Quarterly Return on Equity rose 1.0% to 0.01% in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2021, up 1.0% year-over-year, with the annual reading at 0.01% for FY2021, 1.0% up from the prior year.
  • Return on Equity was 0.01% for Q4 2021 at ENDRA Life Sciences, down from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.03% in Q1 2017 and troughed at 0.13% in Q3 2018.
  • The 5-year median for Return on Equity is 0.02% (2020), against an average of 0.03%.
  • Year-over-year, Return on Equity dropped -13bps in 2018 and then grew 8bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2017, then plummeted by -291bps to 0.03% in 2018, then dropped by -28bps to 0.04% in 2019, then skyrocketed by 48bps to 0.02% in 2020, then skyrocketed by 58bps to 0.01% in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Return on Equity are 0.01% (Q4 2021), 0.01% (Q3 2021), and 0.01% (Q2 2021).